ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Antidiabetic Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18M7552
Home | Market Reports | Health| Pharmacy| Drugs & Medications
China Oral Antidiabetic Drugs Market Report Forecast 2021 2027
BUY CHAPTERS

Global Oral Antidiabetic Drugs Market Research Report 2025

Code: QYRE-Auto-18M7552
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Abbott
Biocon Ltd.
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer Inc
Huadong Medicine Co.,Ltd
Lepu Medical
Hengrui Medicine

Oral Antidiabetic Drugs Market Size

The global market for Oral Antidiabetic Drugs was valued at US$ 1914 million in the year 2024 and is projected to reach a revised size of US$ 2363 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Oral Antidiabetic Drugs Market

Oral Antidiabetic Drugs Market

Oral antidiabetic drugs are medications used to manage blood glucose levels in individuals with type 2 diabetes. They work by improving insulin sensitivity, increasing insulin production, or reducing glucose production in the liver.
The market for oral antidiabetic drugs is driven by the growing prevalence of type 2 diabetes and the need for effective and convenient glucose-lowering medications. The market"s growth is also influenced by ongoing research in diabetes therapeutics, leading to the development of new drug classes and combination therapies.
This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic Drugs.
The Oral Antidiabetic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Antidiabetic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Antidiabetic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oral Antidiabetic Drugs Market Report

Report Metric Details
Report Name Oral Antidiabetic Drugs Market
Accounted market size in year US$ 1914 million
Forecasted market size in 2031 US$ 2363 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck, Pfizer, Huadong Medicine Co.,Ltd., Lepu Medical, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oral Antidiabetic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Antidiabetic Drugs Market growing?

Ans: The Oral Antidiabetic Drugs Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Oral Antidiabetic Drugs Market size in 2031?

Ans: The Oral Antidiabetic Drugs Market size in 2031 will be US$ 2363 million.

Who are the main players in the Oral Antidiabetic Drugs Market report?

Ans: The main players in the Oral Antidiabetic Drugs Market are Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck, Pfizer, Huadong Medicine Co.,Ltd., Lepu Medical, Hengrui Medicine

What are the Application segmentation covered in the Oral Antidiabetic Drugs Market report?

Ans: The Applications covered in the Oral Antidiabetic Drugs Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Oral Antidiabetic Drugs Market report?

Ans: The Types covered in the Oral Antidiabetic Drugs Market report are Sulfonylureas, Meglitinides, Alpha-glucosidase inhibitors

Recommended Reports

Oral Antidiabetic Markets

Diabetes Therapeutics

Other Oral Drug Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Alpha-glucosidase inhibitors
1.3 Market by Application
1.3.1 Global Oral Antidiabetic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic Drugs Market Perspective (2020-2031)
2.2 Global Oral Antidiabetic Drugs Growth Trends by Region
2.2.1 Global Oral Antidiabetic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral Antidiabetic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Oral Antidiabetic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Oral Antidiabetic Drugs Market Dynamics
2.3.1 Oral Antidiabetic Drugs Industry Trends
2.3.2 Oral Antidiabetic Drugs Market Drivers
2.3.3 Oral Antidiabetic Drugs Market Challenges
2.3.4 Oral Antidiabetic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antidiabetic Drugs Players by Revenue
3.1.1 Global Top Oral Antidiabetic Drugs Players by Revenue (2020-2025)
3.1.2 Global Oral Antidiabetic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Oral Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral Antidiabetic Drugs Revenue
3.4 Global Oral Antidiabetic Drugs Market Concentration Ratio
3.4.1 Global Oral Antidiabetic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Drugs Revenue in 2024
3.5 Global Key Players of Oral Antidiabetic Drugs Head office and Area Served
3.6 Global Key Players of Oral Antidiabetic Drugs, Product and Application
3.7 Global Key Players of Oral Antidiabetic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic Drugs Breakdown Data by Type
4.1 Global Oral Antidiabetic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Oral Antidiabetic Drugs Forecasted Market Size by Type (2026-2031)
5 Oral Antidiabetic Drugs Breakdown Data by Application
5.1 Global Oral Antidiabetic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Oral Antidiabetic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oral Antidiabetic Drugs Market Size (2020-2031)
6.2 North America Oral Antidiabetic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral Antidiabetic Drugs Market Size by Country (2020-2025)
6.4 North America Oral Antidiabetic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Antidiabetic Drugs Market Size (2020-2031)
7.2 Europe Oral Antidiabetic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral Antidiabetic Drugs Market Size by Country (2020-2025)
7.4 Europe Oral Antidiabetic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antidiabetic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Oral Antidiabetic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Antidiabetic Drugs Market Size (2020-2031)
9.2 Latin America Oral Antidiabetic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral Antidiabetic Drugs Market Size by Country (2020-2025)
9.4 Latin America Oral Antidiabetic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antidiabetic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Oral Antidiabetic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral Antidiabetic Drugs Introduction
11.1.4 Eli Lilly Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.1.5 Eli Lilly Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Oral Antidiabetic Drugs Introduction
11.2.4 Abbott Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Biocon
11.3.1 Biocon Company Details
11.3.2 Biocon Business Overview
11.3.3 Biocon Oral Antidiabetic Drugs Introduction
11.3.4 Biocon Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.3.5 Biocon Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antidiabetic Drugs Introduction
11.4.4 Sanofi Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Sunpharma
11.5.1 Sunpharma Company Details
11.5.2 Sunpharma Business Overview
11.5.3 Sunpharma Oral Antidiabetic Drugs Introduction
11.5.4 Sunpharma Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.5.5 Sunpharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Oral Antidiabetic Drugs Introduction
11.6.4 Novartis Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Oral Antidiabetic Drugs Introduction
11.7.4 Novo Nordisk Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.7.5 Novo Nordisk Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Oral Antidiabetic Drugs Introduction
11.8.4 Merck Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oral Antidiabetic Drugs Introduction
11.9.4 Pfizer Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Huadong Medicine Co.,Ltd.
11.10.1 Huadong Medicine Co.,Ltd. Company Details
11.10.2 Huadong Medicine Co.,Ltd. Business Overview
11.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Introduction
11.10.4 Huadong Medicine Co.,Ltd. Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.10.5 Huadong Medicine Co.,Ltd. Recent Development
11.11 Lepu Medical
11.11.1 Lepu Medical Company Details
11.11.2 Lepu Medical Business Overview
11.11.3 Lepu Medical Oral Antidiabetic Drugs Introduction
11.11.4 Lepu Medical Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.11.5 Lepu Medical Recent Development
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Details
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine Oral Antidiabetic Drugs Introduction
11.12.4 Hengrui Medicine Revenue in Oral Antidiabetic Drugs Business (2020-2025)
11.12.5 Hengrui Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eli Lilly
Abbott
Biocon Ltd.
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer Inc
Huadong Medicine Co.,Ltd
Lepu Medical
Hengrui Medicine
List of Tables
 Table 1. Global Oral Antidiabetic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Sulfonylureas
 Table 3. Key Players of Meglitinides
 Table 4. Key Players of Alpha-glucosidase inhibitors
 Table 5. Global Oral Antidiabetic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Oral Antidiabetic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Oral Antidiabetic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Oral Antidiabetic Drugs Market Share by Region (2020-2025)
 Table 9. Global Oral Antidiabetic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Oral Antidiabetic Drugs Market Share by Region (2026-2031)
 Table 11. Oral Antidiabetic Drugs Market Trends
 Table 12. Oral Antidiabetic Drugs Market Drivers
 Table 13. Oral Antidiabetic Drugs Market Challenges
 Table 14. Oral Antidiabetic Drugs Market Restraints
 Table 15. Global Oral Antidiabetic Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Oral Antidiabetic Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Oral Antidiabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2024)
 Table 18. Ranking of Global Top Oral Antidiabetic Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Oral Antidiabetic Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Oral Antidiabetic Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Oral Antidiabetic Drugs, Product and Application
 Table 22. Global Key Players of Oral Antidiabetic Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Oral Antidiabetic Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Oral Antidiabetic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Oral Antidiabetic Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Oral Antidiabetic Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Oral Antidiabetic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Oral Antidiabetic Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Oral Antidiabetic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Oral Antidiabetic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Oral Antidiabetic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Oral Antidiabetic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Oral Antidiabetic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Oral Antidiabetic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Oral Antidiabetic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Eli Lilly Company Details
 Table 48. Eli Lilly Business Overview
 Table 49. Eli Lilly Oral Antidiabetic Drugs Product
 Table 50. Eli Lilly Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 51. Eli Lilly Recent Development
 Table 52. Abbott Company Details
 Table 53. Abbott Business Overview
 Table 54. Abbott Oral Antidiabetic Drugs Product
 Table 55. Abbott Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 56. Abbott Recent Development
 Table 57. Biocon Company Details
 Table 58. Biocon Business Overview
 Table 59. Biocon Oral Antidiabetic Drugs Product
 Table 60. Biocon Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 61. Biocon Recent Development
 Table 62. Sanofi Company Details
 Table 63. Sanofi Business Overview
 Table 64. Sanofi Oral Antidiabetic Drugs Product
 Table 65. Sanofi Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 66. Sanofi Recent Development
 Table 67. Sunpharma Company Details
 Table 68. Sunpharma Business Overview
 Table 69. Sunpharma Oral Antidiabetic Drugs Product
 Table 70. Sunpharma Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 71. Sunpharma Recent Development
 Table 72. Novartis Company Details
 Table 73. Novartis Business Overview
 Table 74. Novartis Oral Antidiabetic Drugs Product
 Table 75. Novartis Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 76. Novartis Recent Development
 Table 77. Novo Nordisk Company Details
 Table 78. Novo Nordisk Business Overview
 Table 79. Novo Nordisk Oral Antidiabetic Drugs Product
 Table 80. Novo Nordisk Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 81. Novo Nordisk Recent Development
 Table 82. Merck Company Details
 Table 83. Merck Business Overview
 Table 84. Merck Oral Antidiabetic Drugs Product
 Table 85. Merck Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 86. Merck Recent Development
 Table 87. Pfizer Company Details
 Table 88. Pfizer Business Overview
 Table 89. Pfizer Oral Antidiabetic Drugs Product
 Table 90. Pfizer Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 91. Pfizer Recent Development
 Table 92. Huadong Medicine Co.,Ltd. Company Details
 Table 93. Huadong Medicine Co.,Ltd. Business Overview
 Table 94. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product
 Table 95. Huadong Medicine Co.,Ltd. Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 96. Huadong Medicine Co.,Ltd. Recent Development
 Table 97. Lepu Medical Company Details
 Table 98. Lepu Medical Business Overview
 Table 99. Lepu Medical Oral Antidiabetic Drugs Product
 Table 100. Lepu Medical Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 101. Lepu Medical Recent Development
 Table 102. Hengrui Medicine Company Details
 Table 103. Hengrui Medicine Business Overview
 Table 104. Hengrui Medicine Oral Antidiabetic Drugs Product
 Table 105. Hengrui Medicine Revenue in Oral Antidiabetic Drugs Business (2020-2025) & (US$ Million)
 Table 106. Hengrui Medicine Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Oral Antidiabetic Drugs Picture
 Figure 2. Global Oral Antidiabetic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Antidiabetic Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Sulfonylureas Features
 Figure 5. Meglitinides Features
 Figure 6. Alpha-glucosidase inhibitors Features
 Figure 7. Global Oral Antidiabetic Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Oral Antidiabetic Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Others Case Studies
 Figure 12. Oral Antidiabetic Drugs Report Years Considered
 Figure 13. Global Oral Antidiabetic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Oral Antidiabetic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Oral Antidiabetic Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Oral Antidiabetic Drugs Market Share by Players in 2024
 Figure 17. Global Top Oral Antidiabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Oral Antidiabetic Drugs Revenue in 2024
 Figure 19. North America Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Oral Antidiabetic Drugs Market Share by Country (2020-2031)
 Figure 21. United States Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Oral Antidiabetic Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Oral Antidiabetic Drugs Market Share by Region (2020-2031)
 Figure 33. China Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Oral Antidiabetic Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Oral Antidiabetic Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Oral Antidiabetic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 49. Abbott Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 50. Biocon Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 51. Sanofi Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 52. Sunpharma Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 53. Novartis Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 54. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 55. Merck Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 56. Pfizer Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 57. Huadong Medicine Co.,Ltd. Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 58. Lepu Medical Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 59. Hengrui Medicine Revenue Growth Rate in Oral Antidiabetic Drugs Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Oral Anti Diabetic Drug Market Insights Forecast to 2030
Global Oral Antidiabetic Agents Market Insights Forecast to 2030
Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Hypoglycemic Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypoglycemic Drugs Market Insights Forecast to 2030
Global Oral Antidiabetic OAD Treatment Market Research Report 2024
Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Oral Anti diabetes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Hypoglycemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Insulin Market Research Report 2025
Oral Blood Glucose Regulators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiabetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Glucose Market Research Report 2025
Global Semaglutide Oral Drug Market Research Report 2024
Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Diabetes Care Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Medication for Facial Features Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4D16704
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions